Cargando…

BCL11A Is Oncogenic and Predicts Poor Outcomes in Natural Killer/T-Cell Lymphoma

The current treatment for natural killer/T-cell lymphoma (NKTL) among advanced/relapsed patients is unsatisfying, thereby highlighting the need for novel therapeutic targets. B‐cell chronic lymphocytic leukemia/lymphoma 11 A (BCL11A), as a transcription factor, is oncogenic in several neoplasms. How...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Hongyun, Li, Chun, Feng, Wei, Yue, Jianjun, Song, Jingfang, Peng, Aizhi, Wang, Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7311857/ https://www.ncbi.nlm.nih.gov/pubmed/32625084 http://dx.doi.org/10.3389/fphar.2020.00820

Ejemplares similares

Oncogenic Network and Hub Genes for Natural Killer/T-Cell Lymphoma Utilizing WGCNA
por: Liu, Huijiao, et al.
Publicado: (2020)

Prognostic Value of the Modified Systemic Inﬂammation Score in Patients With Extranodal Natural Killer/T-Cell Lymphoma
por: Huang, He, et al.
Publicado: (2020)

RUNX3 is oncogenic in natural killer/T-cell lymphoma and is transcriptionally regulated by MYC
por: Selvarajan, V, et al.
Publicado: (2017)

Advantages and applications of CAR-expressing natural killer cells
por: Glienke, Wolfgang, et al.
Publicado: (2015)

Extranodal natural killer/T‐cell lymphoma in an 11‐year‐old child
por: Ninchoji, Takeshi, et al.
Publicado: (2020)

Correlation Between C-MYC, BCL-2, and BCL-6 Protein Expression and Gene Translocation as Biomarkers in Diagnosis and Prognosis of Diffuse Large B-cell Lymphoma
por: Zhang, YunXiang, et al.
Publicado: (2019)

Salvia Miltiorrhiza Ameliorates Liver Fibrosis by Activating Hepatic Natural Killer Cells in Vivo and in Vitro
por: Peng, Yuan, et al.
Publicado: (2018)

Natural killer cell-related prognosis signature predicts immune response in colon cancer patients
por: Li, Meiqin, et al.
Publicado: (2023)

Selective targeting of BCL6 induces oncogene addiction switching to BCL2 in B-cell lymphoma
por: Dupont, Thibault, et al.
Publicado: (2015)

Novel target and treatment agents for natural killer/T-cell lymphoma
por: Tian, Xiao-Peng, et al.
Publicado: (2023)

VISTA and PD-L1 synergistically predict poor prognosis in patients with extranodal natural killer/T-cell lymphoma
por: He, Hai-Xia, et al.
Publicado: (2021)

T-cell dysfunction in natural killer/T-cell lymphoma
por: Feng, Xiaoyan, et al.
Publicado: (2023)

Primary Natural Killer/T-Cell Lymphoma of the Ribs
por: Kim, Kyoung Min, et al.
Publicado: (2023)

Increased serum levels of interleukin-10 predict poor prognosis in extranodal natural killer/T-cell lymphoma patients receiving asparaginase-based chemotherapy
por: Wang, Hua, et al.
Publicado: (2015)

A Case of Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type with Dermatomyositis
por: Gong, Yu, et al.
Publicado: (2021)

PB2370: EXTRANODAL NATURAL KILLER (NK)/T-CELL LYMPHOMA, NASAL-TYPE: ABOUT 11 CASES
por: Aghoutane, Yossra, et al.
Publicado: (2023)

Calreticulin increases growth and progression of natural killer/T-cell lymphoma
por: Zheng, Yan, et al.
Publicado: (2020)

Cell cycle progression dictates the requirement for BCL2 in natural killer cell survival
por: Viant, Charlotte, et al.
Publicado: (2017)

Asparagine synthetase expression is associated with the sensitivity to asparaginase in extranodal natural killer/T-cell lymphoma in vivo and in vitro
por: Liu, Wen-jian, et al.
Publicado: (2018)

Pharmacokinetic Behavior of Vincristine and Safety Following Intravenous Administration of Vincristine Sulfate Liposome Injection in Chinese Patients With Malignant Lymphoma
por: Yang, Fen, et al.
Publicado: (2018)

Neurolymphomatosis Caused by Nasal-type Extranodal Natural Killer/T-cell Lymphoma
por: Yi, Fang-Fang, et al.
Publicado: (2017)

DNA methylation prevents CTCF-mediated silencing of the oncogene BCL6 in B cell lymphomas
por: Lai, Anne Y., et al.
Publicado: (2010)

Extranodal Natural-Killer/T-Cell Lymphoma, Nasal Type
por: Gill, Harinder, et al.
Publicado: (2010)

Treatment outcome of nasal natural killer/T-cell lymphoma
por: Lee, Hyun Jin, et al.
Publicado: (2011)

Delayed Diagnosis of Nasal Natural Killer/T-Cell Lymphoma
por: Villwock, Jennifer A., et al.
Publicado: (2013)

Extranodal natural killer/T-cell lymphoma of the tenosynovium of the hand
por: Lim, Yoo Li, et al.
Publicado: (2015)

Pathogenesis and biomarkers of natural killer T cell lymphoma (NKTL)
por: Somasundaram, Nagavalli, et al.
Publicado: (2019)

Advances in multiple omics of natural-killer/T cell lymphoma
por: Xiong, Jie, et al.
Publicado: (2018)

Extranodal Natural Killer/T-Cell Lymphoma: An Incidental Finding
por: Althoff, Ashley, et al.
Publicado: (2017)

Non-coding RNAs in Natural Killer/T-Cell Lymphoma
por: Mei, Mei, et al.
Publicado: (2019)

Updating targets for natural killer/T-cell lymphoma immunotherapy
por: Xue, Weili, et al.
Publicado: (2021)

Recurrent GNAQ mutation encoding T96S in natural killer/T cell lymphoma
por: Li, Zhaoming, et al.
Publicado: (2019)

Decreased apolipoprotein A-I level indicates poor prognosis in extranodal natural killer/T-cell lymphoma, nasal type
por: Quan, Qi, et al.
Publicado: (2016)

The Role of PD-L1 Expression in Prediction and Stratification of Recurrent or Refractory Extranodal Natural Killer/T-Cell Lymphoma
por: Gao, Li-Min, et al.
Publicado: (2022)

High Pretreatment D-Dimer Levels Correlate with Adverse Clinical Features and Predict Poor Survival in Patients with Natural Killer/T-Cell Lymphoma
por: Bi, Xi-wen, et al.
Publicado: (2016)

Epigenetic aberrations in natural killer/T-cell lymphoma: diagnostic, prognostic and therapeutic implications
por: Küçük, Can, et al.
Publicado: (2020)

Overexpression of MYC and BCL2 Predicts Poor Prognosis in Patients with Extranodal NK/T-cell Lymphoma, Nasal Type
por: Wang, Jing-hua, et al.
Publicado: (2017)

Bcl-xL activity influences outcome of the mitotic arrest
por: Suleimenov, M., et al.
Publicado: (2022)

Clinical characteristics and treatment of 69 patients with extranodal natural killer T-cell lymphoma
por: Guo, Yuyan, et al.
Publicado: (2016)

Haploinsufficiency of Bcl11b suppresses the progression of ATM-deficient T cell lymphomas
por: Pinkney, Kerice A., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_rbb6i0lqpadp4q7do2osahbqrv